• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1526 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding two genetic variants of Zellweger spectrum disorder to the carrier testing offer for people from the Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord regions]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: diagnostic, prognostic, or predictive multigene panel for non-small cell lung carcinoma (NSCLC) by liquid biopsy (NGS)]
2024 NIHR Health Technology Assessment programme Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis
2024 Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic full thickness resection of colorectal lesions]
2024 NIHR Health Services and Delivery Research programme Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCT
2024 NIHR Health Services and Delivery Research programme Why do acute healthcare staff behave unprofessionally towards each other and how can these behaviours be reduced? A realist review
2024 NIHR Health and Social Care Delivery Program Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation
2024 NIHR Health and Social Care Delivery Program Community-based complex interventions to sustain independence in older people, stratified by frailty: a systematic review and network meta-analysis
2024 NIHR Health and Social Care Delivery Program Improving the integration of care for trans adults: ICTA a mixed-methods study
2024 NIHR Health and Social Care Delivery Program The Resilience Hub approach for addressing mental health of health and social care workers during the COVID-19 pandemic: a mixed-methods evaluation
2024 NIHR Health and Social Care Delivery Program Interventions to minimise hospital winter pressures related to discharge planning and integrated care: a rapid mapping review of UK evidence
2024 NIHR Health and Social Care Delivery Program Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model
2024 NIHR Health and Social Care Delivery Program Integrating palliative care and heart failure: the PalliatHeartSynthesis realist synthesis
2024 NIHR Health Technology Assessment programme Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT
2024 NIHR Health Technology Assessment programme Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation
2024 Penn Medicine Center for Evidence-based Practice (CEP) Impact of workforce racial and ethnic diversity on patient health and healthcare outcomes
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: COVID-19 - optimal use of parmacological treatments]
2024 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism by MS/MS. Update: Carnitine uptake deficiency; very long chain acyl-CoA dehydrogenase deficiency]
2024 WorkSafeBC Effectiveness of prolotherapy in shoulder labral tears
2024 WorkSafeBC Effectiveness of extra corporeal shockwave therapy (ESWT) in treating shoulder labral tears
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: blood quantification of ruxolitinib by high-performance liquid chromatographytandem mass spectrometry (HPLC-MS/MS)]
2024 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism by MS/MS. Update and assessment regional programs. Methylmalonic acidemias; Propionic acidaemia]
2024 NIHR Health Technology Assessment programme Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: blood quantification of fludarabine by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)]
2024 NIHR Health and Social Care Delivery Program Understanding and improving the quality of primary care for people in prison: a mixed-methods study
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: evaluation of the lung cancer screening pilot project - effects on participants' health and organizational impact on the healthcare system]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of placental growth factor (PlGF) testing in suspected preeclampsia]
2024 NIHR Health Technology Assessment programme Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model
2024 WorkSafeBC Effectiveness of prolotherapy in rotator cuff tendinopathy
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: quantification of antipsychotics in serum using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS)]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: genital herpes - identification, diagnosis, optimal use of antivirals and follow-up]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: syndromic approach - pharmacological treatment]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: confirmed chlamydia trachomatis or neisseria gonorrhoeae infection]
2024 Austrian Institute for Health Technology Assessment (AIHTA) Mental health screening of adults in primary care
2024 Austrian Institute for Health Technology Assessment (AIHTA) Artificial Intelligence in health care with a focus on hospitals: methodological considerations for health technology assessment: a scoping review
2024 Canary Health Service [Cost-effectiveness of neonatal screening for spinal muscular atrophy and severe combined immunodeficiency]
2024 Ontario Health Interferon-gamma release assay testing for latent tuberculosis infection
2024 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Safety, efficacy, effectiveness, and efficiency of systematic neonatal screening for the detection of congenital cytomegalovirus]
2024 Institute of Health Economics (IHE) Mammography screening for breast cancer: a replication of a systematic review of observational studies to inform an update of the Canadian Task Force on Preventive Health Care guidelines
2024 Center for Drug Evaluation (CDE) [HTA Full report-Cost-effectiveness analysis of Pap smear screening and HPV testing]
2024 Center for Drug Evaluation (CDE) [HTA Full report-Cost-effectiveness analysis of adjusting the age and frequency of mammography subsidies]
2024 Malaysian Health Technology Assessment (MaHTAS) Wide field digital eye imaging system for universal neonatal eye screening
2024 Malaysian Health Technology Assessment (MaHTAS) Transcranial direct current stimulation (tDCS) for depression and schizophrenia
2024 Malaysian Health Technology Assessment (MaHTAS) Podoscope for footprint analysis
2024 Malaysian Health Technology Assessment (MaHTAS) Handheld fundus camera - an update
2024 Malaysian Health Technology Assessment (MaHTAS) Computer aided-detection or artificial intelligence for chest X-ray in early detection of tuberculosis
2023 Health Information and Quality Authority (HIQA) Health technology assessment of the addition of severe combined immunodeficiency (SCID) to the National Newborn Bloodspot Screening Programme
2023 Ontario Health Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts
2023 Health Information and Quality Authority (HIQA) Health technology assessment of the addition of severe combined immunodeficiency (SCID) to the National Newborn Bloodspot Screening Programme
2023 Health Information and Quality Authority (HIQA) A rapid health technology assessment of gene expression profiling tests for guiding the use of adjuvant chemotherapy in early-stage invasive breast cancer
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: characteristics and needs of targeted rehabilitation clienteles for young people with adjustment problems aged 10 or older]
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Evaluation of the lung cancer screening program]
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Ovarian tissue cryopreservation and transplantation in patients with cancer or benign diseases to fertility preservation]
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Early detection tools for emotional distress in adult people with cancer]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for glutaric acidemia type 1 (GA1)]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for for long-chain acyl-CoA dehydrogenase deficiency (LCHADD) and mitochondrial trifunctional protein deficiency (TFPD)]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2023 NIHR Health Technology Assessment programme Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: Syphilis - detection, diagnosis, optimal antibiotic use, and follow-up]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: NK cell degranulation (natural killer)]
2023 NIHR Health and Social Care Delivery Program Mental health crisis care for children and young people aged 5 to 25 years: the CAMH-Crisis evidence synthesis
2023 NIHR Health Technology Assessment programme Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding the HbS/E, HbE/E and HbE/β-thal variants to the primary targets of the neonatal screening test for hemoglobinopathies]
2023 Austrian Institute for Health Technology Assessment (AIHTA) Perinatal and infant mental health care in Austria. A mapping of existing prevention, screening and care structures, with a specific focus on Tyrol
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: principles and criteria for gene selection for the molecular diagnosis of constitutional genetic diseases by next-generation sequencing - Report in support of the deployment of the sequencing service]
2023 Penn Medicine Center for Evidence-based Practice (CEP) Urine pregnancy screening for patients with and without the capacity for pregnancy
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: measurement and monitoring of total serum bilirubin in a newborn with signs suggestive of neonatal jaundice]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optical genome mapping - diagnosis and prognostic stratification of hematological malignancies]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: virtual care in hematology/oncology]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Rapid response: Cervical cancer: transition from from Pap test screening to HPV testing]
2023 NIHR Health Services and Delivery Research programme What happens after an NHS Health Check? A survey and realist review
2023 NIHR Health Services and Delivery Research programme Identifying models of care to improve outcomes for older people with urgent care needs: a mixed methods approach to develop a system dynamics model
2023 NIHR Health Services and Delivery Research programme Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evaluation of invitation letters and information for insured persons on colorectal cancer screening]
2023 NIHR Health Services and Delivery Research programme Reducing unplanned hospital admissions from care homes: a systematic review
2023 NIHR Health Technology Assessment programme Online remote behavioural intervention for tics in 9- to 17-year-olds: the ORBIT RCT with embedded process and economic evaluation
2023 NIHR Health Technology Assessment programme Posterior cervical foraminotomy versus anterior cervical discectomy for cervical brachialgia: the FORVAD RCT
2023 NIHR Health Technology Assessment programme Exercise therapy for tendinopathy: a mixed-methods evidence synthesis exploring feasibility, acceptability and effectiveness
2023 NIHR Health Services and Delivery Research programme The effectiveness of sexual assault referral centres with regard to mental health and substance use: a national mixed-methods study – the MiMoS Study
2023 Canary Health Service [Evaluation of the lung cancer screening program]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [At a glance: screening and management algorithm management of precancerous lesions - cervical cancer and population-based screening]
2023 NIHR Health Services and Delivery Research programme Remote monitoring for long-term physical health conditions: an evidence and gap map
2023 Canary Health Service [Cost-effectiveness of newborn screening for tyrosinemia type I (update)]
2023 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost-utility analysis of universal neonatal screening for critical congenital heart disease based on pulsioximetry in Spain]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: urinary tract infection in people aged 14 and over - diagnostic guidelines, optimal use of 1st- and 2nd-line treatments and follow-up ]
2023 Health Information and Quality Authority (HIQA) Health technology assessment of the addition of spinal muscular atrophy (SMA) to the National Newborn Bloodspot Screening Programme
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of Intercept and Mirasol - pathogen reduction technologies for the treatment of labile blood products in Quebec]
2023 Austrian Institute for Health Technology Assessment (AIHTA) SMA therapies: mid- to long-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec and ≥12 months for patients treated with risdiplam or combination therapies
2023 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Safety, efficacy, and economic evaluation of the implementation of an abdominal aortic aneurysm screening program]
2023 Adelaide Health Technology Assessment (AHTA) Newborn bloodspot screening for sickle cell disease
2023 Adelaide Health Technology Assessment (AHTA) Newborn bloodspot screening for sickle cell disease and beta thalassaemia
2023 Ontario Health Carrier screening programs for cystic fibrosis, fragile X syndrome, hemoglobinopathies and thalassemia, and spinal muscular atrophy
2023 Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness and safety of newborn screening for spinal muscular atrophy. Systematic review]
2023 Canary Health Service [Clinical effectiveness and cost-effectiveness of the extension of colorectal cancer screening up to 74 years of age in general population]
2023 Malaysian Health Technology Assessment (MaHTAS) Ultra-portable digital x-ray system for TB screening
2022 Swiss Federal Office of Public Health (FOPH) Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction
2022 Basque Office for Health Technology Assessment (OSTEBA) [Autism spectrum disorder: scientific evidence on its detection, diagnosis and treatment]
2022 Basque Office for Health Technology Assessment (OSTEBA) [Temporary percutaneous circulatory support devices for the treatment and prevention of cardiogenic shock: analysis of efficacy, effectiveness and safety]
2022 NIHR Health Technology Assessment programme Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: practices for screening or reducing psychological symptoms in individuals with a post-COVID-19 condition]